Lipella pharmaceuticals announces completion of first cohort in phase 2a trial of lp-310 for oral lichen planus, advancing to next dose group

Pittsburgh, november 21, 2024 – prism mediawire – lipella pharmaceuticals inc.

LIPO Ratings Summary

LIPO Quant Ranking